Abstract
Introduction
Stevens-Johnson syndrome presents itself with target lesions and bullae of the skin and the mucosae; it is an acute allergic reaction that can be life-threatening. The immunological reaction responsible for the disease is thought to be massive keratinocyte apoptosis [1] . Its ethiology mostly includes sulphonamides, NSAIDS, anti-malarials and anticonvulsant drugs [2] . Here we present a case of Stevens-Johnson sydrome that has developed due to the use of combined medications.
Case
The 18-year-old female patient was hospitalized with the complaints of fever, chills and widespread eruptions all over her body. In her history she had generalized epileptic seizures that have been treated with valproate for the last five years; however, as the seizures could not be controlled with this drug, Lamotrigine was added to her treatment regimen about a month ago. She was also on Paroxetine for her hallucinations. On her physical examination, her general condition was moderate, she was conscious and cooperative with full orientation. Her blood pressure was 100/60 mmHg, HR: 96/min. rhythmic, body temperature was 38 o C. She had generalized desquamation on the face, exfoliating brown squames and plaques on the forehead and the cheeks, erythema and blurring around both eyes, redness, xerosis and desqua of the lips, white-colored membranes on the lip mucosa, brown-pigmented and itchy papules and plaques that did not change color by pressure and some vesicles on her back and hips that were also seen all around her body. There were palmar and plantar xeroses as well. Heart and respiratory sounds were natural upon auscultation. Abdomen examination was normal. Liver and spleen were not palpable. Traube space was open. Hemoglobin was:10.8, WBC:9500, Platelets: 204.000, CRP:36, AST:144, ALT:82, GGT:88, LDH:436, total protein:4.8, albumin:2.9 and globulin:1.9. With these findings, the patient was evaluated as having drug eruptions (SJS). Prednol was administered at a dose of 80 mg and local steroid therapy was initiated. As there was not any satisfactory improvement, the patient was transferred to the intensive care unit. With steroid treatment at the ICU, the lesions regressed very quickly.
Anticonvulsants are important drug groups that can cause SJS ( Figure 1 and Figure 2 ). 
Discussion
Stevens-Johnson syndrome is more common in adults than in children. It has a frequency of 0.4-1.6/1 million individuals per year [3] In our case, in addition to widespread skin involvement, the oral and ocular mucosae were also affected. In the literature, in cases in whom there is widespread body involvement, the mortality is reported as 3-18 % [2] . The use of corticosteroids for the treatment of SJS is controversial [4] ; however, we used steroids in our patient and observed their beneficial effects.
Anticonvulsants are important drug groups that can cause SJS. It is said that when combined antiepileptic medications are used, these compete with glucuronidation metabolism and increase each other's blood levels resulting in severe skin reactions [4] . A study from abroad showed that of 352 SJS cases, 73 (21%) were due to the use of antiepileptics. Of these 73, 36
were attributed to phenobarbital, 14 to phenytoin, 21 to carbamazepin, 13 to valproic acid and 3 to Lamotrigine. The risk of developing SJS was found to be highest within the first 8 weeks following the initiation of treatment while having valproic acid in the combination increased this risk [5] .
In the literature there was a case similar to ours; SJS had developed after the addition of Lamotrigine to the existing valproate treatment regimen in this case. This 6-year-old girl had been on valproate for 4 years while Lamotrigine was added during the last two weeks. She had admitted with the complaints of fever, widespread eruptions on the body, oral mucosa lesions and conjunctivitis and was treated with IVIG and steroids [6] . In another case presentation, in the 24-year-old male patient epileptic seizures could not be controlled with erythematous plaques all over his body. He was diagnosed as SJS. In this study, it was emphasized that the interactions between Lamotrigine and valproate had contributed to the development of SJS [7] . Different than the cases in the literature, our patient was using three medications namely Valproate, Lamotrigine and Paroxetine with potentials to cause significant rashes at the same time.
When Lamotrigine was added to her treatment regimen, our patient had been using valproate for 5 years; she had not been confronted with side effects and had not developed skin lesions, that is why valproate was not considered as an ethiological factor in the developement of Stevens-Johnson syndrome in this patient. Valproate is known to increase the viability of Lamotrigine by decreasing its glucuronidation. This explains why the risk for significant rashes increased when the patient was given Lamotrigine. Even very low concentrations of Paroxetine is a serotonin inhibitor, it demonstrates antidepressant activity during panic disorders, it specifically inhibits the uptake of 5 HT in cerebral neurons. In the literature, in a patient who was using Paroxetine and Sertraline for panic disorder, maculopapullary and ertyhematous rashes developed and these were thought to be due to a cross-reaction between the medications [10] .
With Lamotrigine treatment, the risk for an adult to develop Stevens-Johnson sydrome is 0.3% with the risk of this being highest during the first month of the treatment [11] . However, with the combined use of antiepileptics the risk increases significantly. Therefore, there is the need to monitor each medication seperately and for those medications that can compete with glucuronidation mechanism, we should keep in mind that they can increase each other's blood levels resulting in severe skin reactions. Moreover, as was the case in our patient, when using a concomittant medication having a high risk for severe rashes, such risks can be higher and one should be more attentive about these types of side effects in these instances. When combining medications, an attempt should be made not to combine such medications if possible.
